Circulating Methylated SEPT9 DNA Analyses to Predict Recurrence Risk and Adjuvant Chemotherapy Benefit in Stage II to III Colorectal Cancer.
Yuan Z, Wang S, Ni K, Zhan Y, Ma H, Liu X, Xin R, Zhou X, Liu Z, Zhao X, Yin X, Ping H, Liu Y, Wang W, Yan S, Han Q, Cui W, Zhang X, Zhang Q, Zhang C.
Yuan Z, et al. Among authors: han q.
Med Sci Monit. 2022 Sep 19;28:e937757. doi: 10.12659/MSM.937757.
Med Sci Monit. 2022.
PMID: 36117308
Free PMC article.